Health
Scholar Rock Secures FDA Approval for Groundbreaking SMA Therapy
By Editor • September 11, 2026 • 1 min read
Scholar Rock's Isembyld receives FDA approval as the first therapy targeting muscle loss in spinal muscular atrophy, promising improved patient mobility.
Read more